NCT03267992

Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014

Observational Study of HGE Health Care Solution COPD Co-Pilot AIR™ Application in Subjects Undergoing the PneumRx® Endobronchial Coil Procedure as Part of EU Registry CLN0014

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 9 (actual)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of undertaking CLN0020, which was a Substudy of the European Coil registry (CLN0014), was to investigate the use of COPD Co-Pilot AIR™, a COPD disease management program manufactured and operated by HGE Health Care Solutions, LLC, in participants undergoing the PneumRx Endobronchial Coil Treatment in a post-market setting.

Detailed description

COPD Co-Pilot AIR™ combines a digital respiratory symptom reporting participant application (an "app") with facilitation of rapid personalized clinical recommendations made by the participant's health care provider and communicated to the participant through the application. COPD Co-Pilot AIR™ provides early identification of an increase in a participant's respiratory symptoms relative to the participant's own baseline symptom profile which in turn enables health care providers to rapidly implement modified treatment plans.

Conditions

• COPD Symptoms After Coil Procedure

Interventions

Type	Name	Description
BEHAVIORAL	COPD Co-Pilot AIR App	App. For COPD symptoms after Coil procedure

Timeline

• Start date: 2017-02-10
• Primary completion: 2018-10-20
• Completion: 2018-10-20
• First posted: 2017-08-31
• Last updated: 2021-07-16

Locations

2 sites across 1 country: Switzerland